Tell me if I'm wrong, but I'm still hoping for some kind of news by Wednesday. Weren't we thinking that would possibly happen to help Biocurex make the next loan payment with less shares?
I was thinking that could be as little as a repackaging of the news that Tumor Biology has published the joint Abbot/Biocurex research. Not sure if TB has done that yet though.
There could also be news of any new license agreement, but I'm not holding my breath.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.